Acquisition Announced Sponsor buyer
BGH Capital acquisition of Aspen Pharmacare Asia Pacific business
A$2.4bn consideration
Announced Jun 2026 (approx.)
Advisers
Aspen Pharmacare Asia Pacific business
Target
Not disclosed
BGH Capital
Acquirer
- Legal adviser
- Allens
Team: Tom Story, Emin Altiparmak, Stephanie Kolaczkos, Tom Hodgson, Beatrice Ho, Matthew Joffe, Kei Shishido, Niamh Petchell, William Tudehope, Lauren Mcgrath-Wild, Jessica Mottau, Phil O'Sullivan, Lachlan McNamara, Nick Li, Joshua Fisher, Cassandra Reilly, Monique Lustig, Caroline Ryan, Lauren John, Desmond Yong, Mimi Chester, Ben O'Hoy, Yoni Baker, Aaron Tan, Michael Graves, Kelly Rankin, Rasa Bergin, Monique Scalzo, Emily Johnstone, Katherine McLellan, Heidi Ruckert, Simon Dewberry, Tegan Ayling, Olivia Mueller
- Target
- Aspen Pharmacare Asia Pacific business
- Acquirer
- BGH Capital
- Seller
- Aspen Pharmacare Holdings
- Structure
- Private sale
- Sector
- Biotech and pharmaceuticals
Similar deals
- Telix Pharmaceuticals and ITM Isotope Technologies Munich SE merger Sep 2026 · A$3.3bn · Biotech and pharmaceuticals
- BDT & MSD Partners stake in DBG Health Aug 2025 · A$1.6bn · Biotech and pharmaceuticals
- BDT & MSD Partners stake in DBG Global Enterprises Aug 2025 · A$7bn · Biotech and pharmaceuticals
- Avista Healthcare Partners acquisition of Mayne Pharma Group Feb 2025 · A$672m · Biotech and pharmaceuticals
- TPG acquisition of Agilex Biolabs Sep 2026 · A$160m · Biotech and pharmaceuticals
Sources
- 2 Jun 2026 Allens advises BGH Capital on acquisition of Aspen Pharmacare’s Asia Pacific business allens.com.au